Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
202.5 USD | +0.23% | +6.27% | -21.76% |
02:57pm | Goldman Sachs Adjusts Biogen Price Target to $340 From $393 | MT |
02:39pm | Canaccord Genuity Adjusts Price Target on Biogen to $308 From $305 | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- BIIB Stock
- Revisions Biogen Inc.